DNTH (Dianthus Therapeutics) Pangali Forward P/E

Logo korporat perusahaan Dianthus Pharma (DNTH)

Dianthus Therapeutics (DNTH) is engaged in a high-risk battle for leadership in autoimmune pathology therapy, leveraging unique patents. A focus on rare chronic diagnoses provides the company with long-term revenue in narrow niches. The consensus forward P/E for the company is available in the GURU.Markets terminal, where 0.00 records a new level. However, the absence of profitable assets leaves the business dependent on external investment.

Prakiraan rega marang bathi: Dianthus Therapeutics, Inc. (DNTH) kanggo 21.02.2024 - 15.11.2026

Rincian analitis perusahaan Dianthus Therapeutics

- rega saiki lan proyeksi nilai saham:
Ringkesan analitik perusahaan:dianthustx.com
Sampel barang Dianthus Therapeutics

Dianthus Therapeutics (DNTH) is developing costly R&D projects in the field of rare autoimmune pathologies. This expected price-to-earnings ratio compares the company's current market value with projected earnings. The metric reveals an overvaluation of the asset when quotes rise faster than actual financial prospects. For biopharmaceuticals, this gap is critical due to the volatility of clinical trials. A high ratio signals a speculative bubble and the risk of a sharp correction.

Pesaing Dianthus Therapeutics (DNTH)

Prakiraan rega marang bathi ARGX (Argenx)|BNTX (BioNTech Group) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (Abivax SA)|Kapitalisasi marang proyeksi bathi admabiologics.com (ADMA)|PTGX - Rega marang bathi mangsa ngarep|Immunovant Inc (IMVT) - Prakiraan rega marang bathi|Kiniksa Corp (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols, S.A.|Prakiraan rega marang bathi ADPT|Pangali Forward P/E celldex.com|Rega marang bathi mangsa ngarep Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VERA (veratx.com)|Pharvaris Pharma (PHVS) - Rasio prakiraan rega marang bathi|AbCellera Biologics - Pangali Forward P/E|tourmalinebio.com - Rasio kapitalisasi marang bathi mangsa ngarep|Precigen (PGEN) - Rega marang bathi mangsa ngarep|Pharming Group - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Nektar Therapeutics Inc|UPB (Upstream Pharma) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E ZBIO|Pangali Forward P/E immunome.com (IMNM)|Pangali Forward P/E GOSS (gossamerbio.com)|Kapitalisasi marang proyeksi bathi KalVista Pharma (KALV)|SEPN - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - Pangali Forward P/E|ATXS (Astria Therapeutics, Inc.) - Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Aerovate Therapeutics - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ACRS|Kyverna Therapeutics, Inc - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake TLSA|CABA: Pangali Forward P/E|Prakiraan rega marang bathi Ventyx Bio|Rega marang bathi mangsa ngarep Theratechnologies, Inc.|Rasio prakiraan rega marang bathi Avalo Therapeutics AVTX|Pangali Forward P/E ELDN|AGEN (Agenus, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Rasio prakiraan rega marang bathi|ATYR: Prakiraan rega marang bathi|adagene.com (ADAG) - Prakiraan rega marang bathi|Ikena Oncology (IMA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Shattuck Labs, Inc.|Rega marang bathi mangsa ngarep equilliumbio.com|Prakiraan rega marang bathi connectbiopharm.com (CNTB)|Pangali Forward P/E IMUX|Kapitalisasi marang proyeksi bathi Atara Bio|Rega marang bathi mangsa ngarep InflaRx N.V. IFRX|X4 Pharmaceuticals - Rega marang bathi mangsa ngarep|ACET: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CELU (celularity.com)|INMB: Pangali Forward P/E|BRNS: Rasio kapitalisasi marang bathi mangsa ngarep|KZR (Kezar Life Sciences, Inc.) - Pangali Forward P/E|SAB Biotherapeutics Inc. (SABS) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E AKTX|Rega marang bathi mangsa ngarep ENLV (Enlivex Therapeutics Ltd)|Rega marang bathi mangsa ngarep Q32 Bio Inc. QTTB|GOVX - Prakiraan rega marang bathi|EDSA - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi iBio|CARM: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake XTLB (XTL Biopharmaceuticals, Ltd.)|Rega marang bathi mangsa ngarep boltbio.com|Pangali Forward P/E HCW Biologics|Pangali Forward P/E APVO|AIM - Rasio prakiraan rega marang bathi|Pangali Forward P/E ADTX (Aditxt Inc.)|Kapitalisasi marang proyeksi bathi GRI Bio, Inc. (GRI)|XRTX - Rega marang bathi mangsa ngarep|reshapelifesciences.com (HIND) - Prakiraan rega marang bathi|REVB: Pangali Forward P/E|Indaptus Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Scinai|Rasio prakiraan rega marang bathi CalciMedica, Inc. CALI|Rega marang bathi mangsa ngarep Affimed NV (AFMD)|Pangali Forward P/E Allakos Inc (ALLK)|Rega marang bathi mangsa ngarep hookipapharma.com HOOK|Pangali Forward P/E IGM Biosciences, Inc. IGMS|iTeos Pharma - Pangali Forward P/E|OCEA - Pangali Forward P/E|TCBP: Pangali Forward P/E|Third Harmonic Bio - Pangali mangsa ngarep rega marang bathi